Nothing Special   »   [go: up one dir, main page]

Cassani et al., 2015 - Google Patents

Increased urinary indoxyl sulfate (indican): new insights into gut dysbiosis in Parkinson's disease

Cassani et al., 2015

View PDF
Document ID
8122908360484672469
Author
Cassani E
Barichella M
Cancello R
Cavanna F
Iorio L
Cereda E
Bolliri C
Maria P
Bianchi F
Cestaro B
Pezzoli G
Publication year
Publication venue
Parkinsonism & related disorders

External Links

Snippet

Introduction Changes in the composition of gut microflora have been associated with an increase in chronic diseases. Indican urinary concentration is one of the most common and easily assessable markers of intestinal dysbiosis. Little information is available on intestinal …
Continue reading at www.academia.edu (PDF) (other versions)

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Micro-organisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745Bifidobacteria
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Micro-organisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Hybridisation probes
    • C12Q1/6883Hybridisation probes for diseases caused by alterations of genetic material

Similar Documents

Publication Publication Date Title
Cassani et al. Increased urinary indoxyl sulfate (indican): new insights into gut dysbiosis in Parkinson's disease
Kong et al. Probiotics improve gut microbiota dysbiosis in obese mice fed a high-fat or high-sucrose diet
Myers et al. The gut microbiome in psoriasis and psoriatic arthritis
Kang et al. Alterations in intestinal microbiota diversity, composition, and function in patients with sarcopenia
Solch et al. Mediterranean diet adherence, gut microbiota, and Alzheimer's or Parkinson's disease risk: a systematic review
Basolo et al. Effects of underfeeding and oral vancomycin on gut microbiome and nutrient absorption in humans
Berding et al. Diet can impact microbiota composition in children with autism spectrum disorder
Schwarz et al. Analysis of microbiota in first episode psychosis identifies preliminary associations with symptom severity and treatment response
Lindefeldt et al. The ketogenic diet influences taxonomic and functional composition of the gut microbiota in children with severe epilepsy
Friedman et al. FXR-dependent modulation of the human small intestinal microbiome by the bile acid derivative obeticholic acid
Bernstein Psychological stress and depression: risk factors for IBD?
Nuzum et al. Gut microbiota differences between healthy older adults and individuals with Parkinson’s disease: a systematic review
Wang et al. Effect of probiotics on central nervous system functions in animals and humans: a systematic review
Thaiss et al. Persistent microbiome alterations modulate the rate of post-dieting weight regain
Ghaisas et al. Gut microbiome in health and disease: Linking the microbiome–gut–brain axis and environmental factors in the pathogenesis of systemic and neurodegenerative diseases
De Angelis et al. Autism spectrum disorders and intestinal microbiota
Tamanai-Shacoori et al. Roseburia spp.: a marker of health?
Halmos et al. Diets that differ in their FODMAP content alter the colonic luminal microenvironment
Parthasarathy et al. Relationship between microbiota of the colonic mucosa vs feces and symptoms, colonic transit, and methane production in female patients with chronic constipation
Dewulf et al. Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women
Suez et al. Artificial sweeteners induce glucose intolerance by altering the gut microbiota
Verdam et al. Human intestinal microbiota composition is associated with local and systemic inflammation in obesity
Wang et al. Gastrointestinal microbiota and metabolite biomarkers in children with autism spectrum disorders
Monteleone et al. Multi-omics data integration in anorexia nervosa patients before and after weight regain: A microbiome-metabolomics investigation
Sanz et al. Understanding the role of gut microbes and probiotics in obesity: how far are we?